Gandhi V - Search Results

1

Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.

Balakrishnan K, Burger JA, Quiroga MP, Henneberg M, Ayres ML, Wierda WG, Gandhi V. Balakrishnan K, et al. Among authors: gandhi v. Blood. 2010 Aug 19;116(7):1083-91. doi: 10.1182/blood-2009-10-246199. Epub 2010 May 4. Blood. 2010. PMID: 20442367 Free PMC article.

2

Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy.

Gandhi V, Nowak B, Keating MJ, Plunkett W. Gandhi V, et al. Blood. 1989 Nov 1;74(6):2070-5. Blood. 1989. PMID: 2478221 Free article.

3

Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions.

Gandhi V, Estey E, Keating MJ, Chucrallah A, Plunkett W. Gandhi V, et al. Blood. 1996 Jan 1;87(1):256-64. Blood. 1996. PMID: 8547650 Free article. Clinical Trial.

4

Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response.

Gandhi V, Plunkett W, Rodriguez CO Jr, Nowak BJ, Du M, Ayres M, Kisor DF, Mitchell BS, Kurtzberg J, Keating MJ. Gandhi V, et al. J Clin Oncol. 1998 Nov;16(11):3607-15. doi: 10.1200/JCO.1998.16.11.3607. J Clin Oncol. 1998. PMID: 9817282 Clinical Trial.

5

Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.

Gandhi V, Plunkett W, Weller S, Du M, Ayres M, Rodriguez CO Jr, Ramakrishna P, Rosner GL, Hodge JP, O'Brien S, Keating MJ. Gandhi V, et al. J Clin Oncol. 2001 Apr 15;19(8):2142-52. doi: 10.1200/JCO.2001.19.8.2142. J Clin Oncol. 2001. PMID: 11304766 Clinical Trial.

6

8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells.

Gandhi V, Ayres M, Halgren RG, Krett NL, Newman RA, Rosen ST. Gandhi V, et al. Cancer Res. 2001 Jul 15;61(14):5474-9. Cancer Res. 2001. PMID: 11454694

7

Prolonged infusion of gemcitabine: clinical and pharmacodynamic studies during a phase I trial in relapsed acute myelogenous leukemia.

Gandhi V, Plunkett W, Du M, Ayres M, Estey EH. Gandhi V, et al. J Clin Oncol. 2002 Feb 1;20(3):665-73. doi: 10.1200/JCO.2002.20.3.665. J Clin Oncol. 2002. PMID: 11821446 Clinical Trial.

8

Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.

Rodriguez CO Jr, Mitchell BS, Ayres M, Eriksson S, Gandhi V. Rodriguez CO Jr, et al. Among authors: gandhi v. Cancer Res. 2002 Jun 1;62(11):3100-5. Cancer Res. 2002. PMID: 12036920

9

Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.

Gandhi V, Chen W, Ayres M, Rhie JK, Madden TL, Newman RA. Gandhi V, et al. Cancer Chemother Pharmacol. 2002 Aug;50(2):85-94. doi: 10.1007/s00280-002-0456-0. Epub 2002 Jun 25. Cancer Chemother Pharmacol. 2002. PMID: 12172971

10

Mechanisms for T-cell selective cytotoxicity of arabinosylguanine.

Rodriguez CO Jr, Stellrecht CM, Gandhi V. Rodriguez CO Jr, et al. Among authors: gandhi v. Blood. 2003 Sep 1;102(5):1842-8. doi: 10.1182/blood-2003-01-0317. Epub 2003 May 15. Blood. 2003. PMID: 12750168 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters